Most guidelines agree that well-circumscribed endoscopically detected dysplasia amenable to resection, with
no evidence of dysplasia in the surrounding mucosa or elsewhere in the colon, is appropriate for surveillance. However, the definition of endoscopic resectability will continue to evolve, and consensus is needed for both the terminology and the approach to endoscopically visible and nonvisible dysplasia. “
“Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer (CRC). The role of endoscopy in the management of patients with inflammatory bowel disease (IBD) is well established. However, recent data have shown significant limitations in the effectiveness of the use of colonoscopy to prevent colorectal IWR-1 datasheet cancer (CRC) in patients with IBD colitis. The current standard using random biopsy appeared to be largely ineffective in detecting the nonpolypoid colorectal neoplasms (NP-CRN). Data using chromoendoscopy with targeted biopsy, however, showed a significant improvement when used to detect dysplasia, the best predictor of colorectal cancer risk. The
purpose of this monograph is to provide the medical profession with a useful and organized series of images showing the superficial elevated, flat, and depressed colorectal neoplasms buy Z-VAD-FMK and their appearance after the application of the technique of chromoendoscopy. Figure options Download full-size image Download high-quality image (224 K) Download as
PowerPoint slide Fig. 1. Endoscopic view of nonpolypoid colorectal neoplasm. Figure options Download full-size image Download high-quality image (217 K) Download as PowerPoint slide Fig. 2. Current surveillance against CRC is associated with a high risk of interval cancer. In a study of 55,000 Medicare patients diagnosed with CRC, patients with IBD were 3 times more likely to have had a recent colonoscopy than patients without IBD. A significant fraction (15%) of the IBD patients who were diagnosed with CRC had undergone surveillance colonoscopy in the prior 3 years. Note that many of these cancers were advanced. These data indicate that the standard method used during surveillance colonoscopy, Neratinib namely the random biopsy technique, is inadequate.1 Figure options Download full-size image Download high-quality image (191 K) Download as PowerPoint slide Fig. 3. Random biopsy without interpreting what is being viewed is not effective. This example shows that random biopsy of the colon to detect and diagnose dysplasia has a high miss rate.2 In this patient, random biopsies were taken from the circled areas, as shown by the blood. Unfortunately the neoplasia (encircled by the dashed line) was not biopsied. Note that the high-definition adult colonoscope was used, and the lesion was not detected. High definition increases the resolution of the image.